| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/25/2002 | WO2002057297A1 Use of zpr1 as a molecular probe for spinal muscular atrophy |
| 07/25/2002 | WO2002057294A2 Zinc finger proteins for dna binding and gene regulation in plants |
| 07/25/2002 | WO2002057293A2 Modified zinc finger binding proteins |
| 07/25/2002 | WO2002057292A2 15569, a novel human g protein coupled receptor and uses therefor |
| 07/25/2002 | WO2002057291A2 Hla-dr2 binding peptides |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056902A2 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 07/25/2002 | WO2002056900A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 07/25/2002 | WO2002056837A2 Inhibition of protein-phosphatases for the treatment of heart failure |
| 07/25/2002 | WO2002056831A2 Immunogenic proteoliposomes, and uses thereof |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002056828A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/25/2002 | WO2002056753A2 P27 prevents cellular migration |
| 07/25/2002 | WO2002056701A2 Gelling vegetable protein |
| 07/25/2002 | WO2002042322A3 Mammalian nuclear receptor cofactors cf7 and cf8 and methods of use |
| 07/25/2002 | WO2002041757A3 Hyaline cartilage replacement substance |
| 07/25/2002 | WO2002040511A9 Dna sequence and microcine from escherichia coli strain dsm 6601 |
| 07/25/2002 | WO2002040041A3 Orally ingestible preparation of mistletoe lectins and method |
| 07/25/2002 | WO2002033085A9 Wisp polypeptides and therapeutical applications thereof |
| 07/25/2002 | WO2002032941A3 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/25/2002 | WO2002024731A3 Regulation of human fgd1-like protein |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002019968A9 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
| 07/25/2002 | WO2002018571A3 Human phermone polypeptides |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002013765A3 Malaria immunogen and vaccine |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002006463A3 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002004496A3 Fimh adhesin proteins and methods of use |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001096371A3 Adipose-related gene |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001092891A3 Regulating lipid levels via the zmax1 or hbm gene |
| 07/25/2002 | WO2001088126A3 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 07/25/2002 | WO2001085940A3 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 07/25/2002 | WO2001082788A3 Compounds and methods for the treatment and prevention of bacterial infection |
| 07/25/2002 | WO2001077384A3 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
| 07/25/2002 | WO2001077332A3 Compositions and methods related to canine igg and canine il-13 receptors |
| 07/25/2002 | WO2001076457B1 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 07/25/2002 | WO2001075093A8 Novel nucleic acids and polypeptides |
| 07/25/2002 | WO2001072798A3 Regulation of human oatp2-related protein |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001066750A3 G protein-coupled receptors |
| 07/25/2002 | WO2001062929A3 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001042297A9 Clasp-3 transmembrane protein |
| 07/25/2002 | WO2001033945A8 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 07/25/2002 | WO2001032204A3 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 07/25/2002 | WO2001030812A9 Activation of hcv-specific t cells |
| 07/25/2002 | WO2001025275A9 Regulatory/unfolding peptides of ezrin |
| 07/25/2002 | WO2001018250A3 Single nucleotide polymorphisms in genes |
| 07/25/2002 | WO2001015676A3 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001003723A9 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/25/2002 | WO2001002574A9 Negative regulators of systemic acquired resistance |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001001150A9 Diagnostic test for thrombotic or thromboembolic disease |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | WO2001000791A9 Stress-responsive induction of a therapeutic agent and methods of use |
| 07/25/2002 | WO2001000673A9 Membrane-associated and secreted proteins and uses thereof |
| 07/25/2002 | WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/25/2002 | WO2000052153A3 Method to identify ligands for orphan receptors |
| 07/25/2002 | US20020100080 Insecticidal protein for use in biological pest control |
| 07/25/2002 | US20020100079 Maize metallothionein gene and promoter |
| 07/25/2002 | US20020100078 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 07/25/2002 | US20020100073 Expressing somatotropin in plants; obtain cells, transform, propagate plant, recover fusion protein from seeds |
| 07/25/2002 | US20020100071 Transgenic mouse with endogenous endoglin gene disruption |
| 07/25/2002 | US20020100070 Expression vectors coding polypeptide for use as tool in genetic engineering; for treatment of pain, tension and lung defects |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020100068 Transgenic mouse for targeted recombination mediated by modified Cre-ER |
| 07/25/2002 | US20020100067 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 07/25/2002 | US20020100066 Negative strand rna viral vector having autonomous replication capability |
| 07/25/2002 | US20020099200 Dna encoding orphan snorf66 receptor |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099198 Human endokine alpha |
| 07/25/2002 | US20020099197 Novel potassium channel molecules and uses therefor |
| 07/25/2002 | US20020099196 Polypeptide for use in the treatment of cancer and hematopoietic defects |
| 07/25/2002 | US20020099193 Nucleotide sequences coding polypeptide for use in controlling gene expression in plants |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099190 Nuclelotide sequences coding protein for use in the treatment and prevention of atherosclerosis, osteoporosis and nervous system disorders |
| 07/25/2002 | US20020099188 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2002 | US20020099183 Process for the preparation of neutrophil inhibitory factor |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099176 Antibodies to human g-protein chemokine receptor hdgnr10 (ccr5receptor) |
| 07/25/2002 | US20020099175 Methods for the synthesis of a modified hemoglobin solution |
| 07/25/2002 | US20020099174 Filtration of plasma mixtures using cellulose-based filter aids |
| 07/25/2002 | US20020099173 Protein specific for cardiac and skeletal muscle |
| 07/25/2002 | US20020099172 Endoderm, cardiac and neural inducing factors - xenopus paraxial protocadherin protein |
| 07/25/2002 | US20020099171 Protein for use as antitumor agent |
| 07/25/2002 | US20020099170 Green fluorescent proteins and blue fluorescent proteins |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099093 For use in testing systemic carnitine deficiency |
| 07/25/2002 | US20020099040 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099027 Novel human thrombospondin repeat proteins and polynucleotides encoding the same |